Back to Top Skip to main content

Understanding the potential of COVID-19 convalescent plasma

Researcher scans a unit of plasma in lab. U.S. Army Sgt. Reginald Miles labels donated liquid plasma at the Landstuhl Blood Donor Center. Researchers are studying COVID-19 convalescent plasma to harness the power of neutralizing antibodies to help patients. (Photo by Volker Ramspott)

Recommended Content:

Coronavirus | Convalescent Plasma Collection Program | Armed Services Blood Program

The Department of Defense has set a goal to collect more than 8,000 donated units of plasma from patients who have recovered from COVID-19 by Sept. 30, 2020. This blood will be used to treat critically ill patients and support the development of an effective treatment against the disease.

Like a missile locking on its target, antibodies attack invaders inside the body with a singularity of purpose: search and destroy. Typically, infection-fighting white blood cells produce antibodies as an appropriate response to an invading germ. In some people whose immune systems can’t mount a sufficient attack against a virus, donated antibodies from another person’s plasma may help. Researchers believe the power of antibodies lies in their ability to bind to a virus and neutralize it, or block it from entering cells, said Dr. Kayvon Modjarrad, director of the Emerging Infectious Diseases Branch at the Walter Reed Army Institute of Research in Silver Spring, Maryland. Modjarrad leads the Army’s COVID-19 vaccine development research.

But not all antibodies are created the same. “Antibodies come in different flavors, some of them are neutralizing and some of them are non-neutralizing and we don’t know exactly which individuals are developing what type of antibody,” said Shelly Krebs, chief of B Cell Biology Core at WRAIR Military HIV Research program.

COVID-19 convalescent plasma, or CCP, from a recovered patient could be a mixture of both neutralizing and non-neutralizing antibodies. In fact, people infected with COVID-19 can have varying antibody responses. Some may not have enough antibodies in their plasma to benefit another patient, which is why CCP first needs to be tested for neutralizing antibody levels before transfusing, explained Modjarrad. His lab works to understand the mechanism of COVID-19 antibodies to predict the levels required to offer a person protection from the virus.

Transfusing antibodies provides short-term immunity as the donor antibodies last several weeks to months inside the body, said Navy Capt. (Dr.) Todd Gleeson of the Navy Bloodborne Infection Management Center, located at Naval Support Activity Bethesda, Maryland. “It is likely that a person with COVID-19 who receives CCP will also still develop their own immune cells and produce antibodies to fight the virus if that person is re-exposed in the future,” said Gleeson, who leads a convalescent plasma study of patients at Walter Reed National Military Medical Center also at NSAB in Bethesda. But scientists just can’t confirm that yet. They hope to uncover the answer and many more as they study CCP and COVID-19 antibodies to better treat patients and develop future vaccines.

Military medical treatment facilities will soon take part in an observational study across the Department of Defense to help researchers track trends among patients with COVID-19. The data will help trace recovered patients to ask for CCP donations as the DoD seeks to build a storehouse of CCP for patients admitted to Military Health System facilities and those deployed outside the U.S., explained Army Col. (Dr.) Andrew Cap, director of research at the Army Institute of Surgical Research in San Antonio, Texas. “The goal is to build a convalescent plasma capability within the DoD, both on the collection and on the treatment side,” said Cap, who helped draft a CCP protocol for the DoD.

Future research may lead to the development of highly concentrated neutralizing antibodies extracted from large quantities of convalescent plasma as a potential therapy for prevention and treatment, added Cap.

Scientists believe monoclonal antibodies—derived from a single immune cell—may also hold potential as both a treatment and preventive measure against COVID-19. Krebs and her team have engineered monoclonal antibodies in the lab by isolating the best neutralizing antibodies from CCP samples to create an army of exact replicas that target the COVID-19 virus down to the atomic level, explained Modjarrad. “We know where and how well it’s going to target, and we know the kinetics of how long it will last in the body and how long it will provide protection,” he explained, noting convalescent plasma does not provide that level of effectiveness. “CCP is not generally used for prevention but for treatment.” Monoclonal antibodies could be used for both treatment and prevention of COVID-19 because the transfused neutralizing antibodies would provide immediate immunity, he added.

Monoclonal antibodies have been in use for decades and revolutionized cancer treatment. Krebs’ lab plans to expand the research into monoclonal antibodies against COVID-19 into animal studies this summer. “Our primary goal is to come up with a treatment for people who have COVID-19,” she said.

Anyone able to donate convalescent plasma should contact the Armed Services Blood Program or go online to find a complete list of available collection centers.

You also may be interested in...

Partnerships, COVID-19 are catalysts for enterprise virtual health

Article
1/14/2021
Image of Mr. Adler with text: "Partnerships, COVID-19 are catalysts for enterprise virtual health."

Jamie Adler, the lead for the DHA’s Virtual Health Clinical Integration Office, discusses the future of virtual health (VH).

Recommended Content:

Coronavirus | Connected Health

COVID-19 hinders blood donations during National Blood Donor Month

Article
1/14/2021
Navy Capt. R. Wade Blizzard, commanding officer of U.S. Navy Support Facility Diego Garcia, donates blood for the Navy Medicine Readiness and Training Units Diego Garcia walking blood bank on Dec. 17, 2020. The walking blood bank is a list of eligible donors who can provide blood in case of emergency. (U.S. Navy photo by Navy Seaman Apprentice Stevin Atkins)

Life-saving blood is in high-demand by the Armed Services Blood Program, as the COVID-19 has negatively impacted donations.

Recommended Content:

Armed Services Blood Program | Public Health | Coronavirus | Holiday Observances

COVID presents new set of challenges for DOD environmental health

Article
1/12/2021
Group of Marines, snowshoeing through the snow

One of the most important factors to take into account when maintaining one’s overall fitness is physical environment.

Recommended Content:

Total Force Fitness in a Pandemic | Reintroducing Total Force Fitness | January Toolkit | Coronavirus | Total Force Fitness

DOD Launches “My MilLife Guide” Text Message Program to Boost Wellness

Article
1/11/2021
The new My MilLife Guide program supports the wellness of the military community.

DoD has launched My MilLife Guide, a new program that sends text messages designed to help the military community boost overall wellness while navigating stresses related to COVID-19.

Recommended Content:

Coronavirus | Public Health | Operation Live Well | Health Readiness

Navy corpsman provides multitude of support to hospital

Article
1/8/2021
Two military personnel, wearing masks, in a supply room looking at the shelves

“Thinking outside the box is what makes a great person, let alone a Sailor," Tie said.

Recommended Content:

Public Health | Coronavirus

MTF facilities, markets set to resume transition heading into 2021

Article
1/6/2021
A military nurse, wearing a mask, prepares a needle for a vaccination

Butler says transition on track.

Recommended Content:

MHS Transformation | Coronavirus

BACH healthcare workers and first responders vaccinated for COVID-19

Article
1/6/2021
Soldier gives a nurse a vaccine in her left arm

BACH now joins other Defense Health Agency military treatment facilities that have received the vaccine, marking the start of a phased-in vaccination program to mitigate the spread of the virus.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit | COVID-19 Toolkit

Countering seasonal depression during the COVID-19 pandemic

Article
1/5/2021
Man with his head in his hands, sitting in front of a Christmas tree

SAD, or sometimes called seasonal depression, is a subtype of a major depressive disorder.

Recommended Content:

Coronavirus | Mental Wellness | Mental Health Care | Depression | Suicide Prevention

MHS operational innovations continue in battle against COVID-19

Article
1/5/2021
Two medical personnel, wearing full PPE, in an operating room

MHS innovations in 2020 include a new registry for real-time COVID-19 data and a system to free up hospital beds and protect patients from the disease.

Recommended Content:

Coronavirus | Research and Innovation | Innovation | Technology

COVID-19 Vaccine Toolkit

Publication
1/5/2021

This toolkit provides communicators across the Military Health System (MHS) with important information about the COVID-19 prevention and vaccination from the CDC to share with patients and health care professionals.

Recommended Content:

Coronavirus | COVID-19 Information for Military Treatment Facility Directors | COVID-19 Vaccine Efforts | COVID-19 Toolkit | COVID-19 Vaccine Toolkit

COVID-19 Social Media Toolkit

Publication
1/5/2021

These messages are provided for you to use on your platforms with any of the images from the COVID-19 Toolkit.

Recommended Content:

Coronavirus

Remote monitoring program enables COVID-19 patients to recover at home

Article
1/4/2021
Two medical personnel, wearing masks, looking at the contents of a home-based COVID treatment kit

The program equips COVID-19 patients needing additional monitoring with a home healthcare kit and 24/7 oversight from registered nurses to ensure a higher level of post-hospital care.

Recommended Content:

Public Health | Coronavirus | Innovation

DHA’s IT innovation continues during COVID-19 pandemic

Article
12/31/2020
Three military personnel, wearing masks, in front of a computer screen

IT innovations keep pace despite COVID-19 road blocks.

Recommended Content:

Coronavirus | Research and Innovation | Technology | MHS GENESIS

DHA-IPM 20-004: Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

<< < 1 2 3 4 5  ... > >> 
Showing results 1 - 15 Page 1 of 26

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.